Its active ingredient, Semaglutide, mimics the GLP-1 hormone to help regulate blood sugar, reduce appetite, and support healthy body weight: Weight management: It reduces appetite and delays gastric emptying (the speed at which food leaves the stomach), supporting gradual weight loss in many individuals, especially those with Type 2 Diabetes
Significant barriers still exist despite established safety profiles, such as high costs that restrict access worldwide, a lack of predictive biomarkers for treatment response, a lack of knowledge about the mechanistics of gut microbiota interactions, and an incomplete understanding of long-term safety, particularly with regard to thyroid and pancreatic effects
For patients struggling with injection anxiety or technique , diabetes specialist nurses offer training and support
Other adverse effects listed in the drugs label include injection site reactions, fatigue, burping, hair loss and gastroesophageal reflux disease
TargetNet: A web service for predicting potential drug-target interaction profiling via multi-target SAR models
While effective, liraglutides average weight loss is smaller than semaglutides and tirzepatides
